Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells
详细信息    查看全文
文摘

Objective

To study the effects of minocycline hydrochloride (MINO) on the formation of tartrate-resistant acid phosphatase (TRAP) staining-positive multinucleated osteoclast-like cells in mouse bone marrow cells (BMCs) treated with 1α,25(OH)2D3 or soluble receptor activator of nuclear factor-κB ligand (s-RANKL).

Materials and methods

Mouse BMCs were cultured in alpha-modified minimum essential medium containing foetal calf serum (10 % ) and tetracyclines (2.5, 5 and 10 μM), such as MINO, tetracycline hydrochloride (TC), oxytetracycline hydrochloride (OXT) or doxycycline (DOXY) in the presence of 1α,25(OH)2D3 (10 nM) or s-RANKL (20 ng/ml) for 7 days, and the number of TRAP staining-positive osteoclast-like cells was counted. In RNA isolated from BMCs treated with 1α,25(OH)2D3 or s-RANKL in the presence or absence of MINO, the expressions of osteoclast differentiation relating to mRNA were analysed by reverse transcription-polymerase chain reaction. Cell viability was examined in mouse BMCs and rabbit osteoclasts treated with MINO (0.25–20 μM and 2–50 μM, respectively) for 24 h.

Results

MINO, TC, OXT or DOXY inhibited 1α,25(OH)2D3-induced osteoclast-like cell formation in mouse BMCs dose dependently. MINO suppressed 1α,25(OH)2D3-induced up-regulation of mRNA expressions of TRAP, cathepsin K, carbonic anhydrase II, and calcitonin receptor, but not RANKL. MINO inhibited s-RANKL-induced osteoclast-like cell formation and up-regulation of mRNA expressions for nuclear factor of activated T-cells c1 (NFATc1), a key regulator of osteoclast differentiation; however, MINO had no effects on the viability of mouse BMCs and rabbit osteoclasts.

Conclusion

MINO inhibits RANKL-induced osteoclastogenesis via down-regulation of NFATc1 mRNA expression in osteoclast precursor cells.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700